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The scientific literature is a well-known source of arguments, which are embedded
in natural language publications. Ontologies and knowledge bases have become
increasingly valuable sources of knowledge synthesized from an ever-increasing body
of scientific publications [Renear and Palmer2009]. We present a motivating scenario
for using argumentation within a scientific knowledge base.
The Drug Interaction Knowledge Base (DIKB) [Boyce et al.2009] is a hand-
constructed evidence-base of safety issues that may occur when two drugs are co-
prescribed and taken together. It collects evidence about pharmacokinetic drug
interactions for over 60 drugs. This sort of evidence can be used to make clinical
decisions on whether it is safe to prescribe two drugs together. This is a complex
decision-making environment: decisions are made under uncertainty and reasonable
people may come to different conclusions, in effect disagreeing with each others’
decisions [Boyce et al.2009]. Using formal argumentation structures could make the
assumptions and logical steps of reasoning open to examination, making the result-
ing knowledge base more robust and trustworthy.
Currently, the DIKB (Version 1.2) has no way to explicitly model the data and
methods in papers, which may need to be reviewed as new knowledge comes to light.
The SWAN Discourse ontology it uses only models evidence in the form of citations
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to an entire paper, with swanco:citesAsSupportingEvidence and
swanco:citesAsRefutingEvidence1 [Ciccarese et al.2008]. Fortunately, a new model
is now available for explicitly modeling data and methods.
Recently, [Clark et al.2014] proposed a new semantic model for claims, evidence,
arguments and annotation in biomedical communications. This model, the Mi-
cropublications ontology,2 is inspired by the Toulmin model of argumentation (and
Verheij’s formalization thereof [Verheij2009]) in order to organize citable claims from
scientific papers into networks of agreement and disagreement. A minimal microp-
ublication is a claim with attribution–as in earlier models such as nanopublica-
tions [Groth et al.2010]. Unlike those models, Micropublications enable explicitly
representing the warrant, i.e. the materials and methods that were used to collect
the data. The data collected is considered meaningful due to a subfield’s approval
of the materials and methods. This approval is the backing of claims made in every-
day science (e.g. ‘paradigm’ science in the terms of [Kuhn2012]). With this model,
truth-bearing Statements (possibly with Qualifiers) from biomedical communica-
tions are explicitly connected to the Data, Material, and Methods. Attribution also
has a place (for instance justifying use of a method by citing it in the literature). A
subargument can be represented as a micropublication for a related claim, however
far back we wish to extend the network.
In ongoing work, we are focusing on creating micropublications through manual
annotation. Currently we are engaging with pharmaceutical curators to envision
the most appropriate way to record evidence for the next generation of the DIKB
knowledge base. Argumentation will play a key part in this model, especially for
auditing the available evidence as the state of knowledge changes. In particular, with
the Micropublications model, “methods and materials later found to be flawed might
be easily traced to claims based upon them” [Clark et al.2014]. This motivates us
to experiment with Micropublications as the underlying model, using a Web-based
1http://swan-ontology.googlecode.com/svn/tags/1.2/swan.owl
2http://purl.org/mp/
Schneider, Boyce, & Horn, Modeling Arguments in Scientific Papers
ArgDiaP 2014: From Real Data to Argument Mining
annotation tool (Domeo3) to help a panel of three drug interaction experts create
the formal markup of a Micropublication. To determine what evidence should be
modeled, we are drawing on new guidelines for systematically evaluating drug-drug
interaction evidence [Scheife et al.2014]. The knowledge representations that result
from this work will enable people to audit the evidence from scientific papers.
Subsequent automation in constructing such knowledge representations is also
conceivable. Previous work has automatically categorized scientific discourse, often
using rhetorical zoning approaches [Teufel1999], and a human annotated corpus can
be used as the basis for predicting patterns on new examples, with supervised ma-
chine learning. Machine learning systems such as SAPIENTA [Liakata et al.2012]
have achieved reasonable accuracy in recognizing Hypothesis, Motivation, Goal, Ob-
ject, Background, Method, Experiment, Model, Observation, Result and Conclusion
in highly-structured texts from chemistry and biochemistry. Previous work studied
the Conclusion category and found that SAPIENTA’s automatically mined effi-
cacy/effectiveness claims compared favorably to manual annotation from the same
abstracts [Boyce et al.2013]. Systematically evaluating drug-drug interaction evi-
dence is a difficult problem, requiring human oversight. For identifying and record-
ing complex evidence, mixed-initiative systems (e.g. [De Liddo et al.2012]) have
been suggested: machine annotation can draw the attention of human curators to
the zones most likely to contain the data and methods that provide evidence about
a harmful drug-drug interaction. Our goal is to transform natural language papers,
with the manual work of expert curators, into elaborated claim-argument networks.
In the future we plan to test what sort of machine annotation can aid human cu-
rators in extracting the evidence recorded in papers and whether expressing the
current evidence on pharmacokinetic drug interactions as micropublications facili-
tates searching and updating knowledge bases.
3http://swan.mindinformatics.org/
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